Back to search
Premenopausal Idiopathic Osteoporosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Premenopausal Idiopathic Osteoporosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Premenopausal Idiopathic Osteoporosis trials you may qualify forThe overarching goal of the research program is to define optimal treatment for premenopausal women with clinically significant fracture syndromes that require…
The primary goal of the study is to assess the extent to which bisphosphonate therapy will prevent decreases in bone mass that may occur after cessation of deno…
The purpose of this research study is to evaluate antiresorptive therapy with denosumab (Prolia) for prevention of bone loss after stopping teriparatide (TPTD)…
Idiopathic osteoporosis (IOP) is defined as osteoporosis that affects young, otherwise completely healthy individuals with no secondary cause of bone loss. In t…
Idiopathic osteoporosis (IOP) is an uncommon disorder in which otherwise healthy young individuals sustain one or more low-trauma fractures. Teriparatide \[PTH(…